CD8A and cancer: We tested whether CD8A could be a reliable prognostic biomarker predicting survival outcome of cancer patients in this study, and results based on pan-cancer datasets in TCGA database revealed its aberrant expression profiles in cancer tissues were tightly associated with patient’s clinical characteristics as well as disease phenotypes.